SPACInsider Logo
Greenrose Acquisition Corp. (GNRSU) Prices $150M IPO
by Kristi Marvin on 2020-02-11 at 8:38am

Greenrose Acquisition Corp. (GNRSU), announced the pricing of their $150 million SPAC IPO this morning and the units are expected to begin trading today, Tuesday, February 11th, under the symbol Nasdaq: GNRSU.

Greenrose will be focusing on companies in the cannabis industry and will be led by William (Mickey) Harley III, as Chief Executive Officer and Director, and Brendan Sheehan, as Executive Vice President, Corporate Strategy and Investor Relations, and Director.

Total SPAC deal count for 2020 year-to-date is now five with $1.287 billion in gross proceeds raised. The offering is anticipated to close on Thursday, February 13, 2020.

Congratulations to all.


Imperial Capital, LLC acted as sole book-running manager for the offering and I-Bankers Securities, Inc. acted as co-manager. Tarter Krinsky & Drogin LLP and K&L Gates LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. Marcum LLP acted as auditor.

 

Recent Posts
by Marlena Haddad on 2022-12-01 at 11:25am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...

by Marlena Haddad on 2022-12-01 at 10:02am

InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...

by Nicholas Alan Clayton on 2022-12-01 at 9:31am

Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...

by Marlena Haddad on 2022-12-01 at 9:22am

Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...

by Nicholas Alan Clayton on 2022-11-30 at 6:01pm

The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved